Venus Remedies surges on reporting 55% jump in Q3 net profit

08 Feb 2013 Evaluate

Venus Remedies is currently trading at Rs. 270.50, up by 23.35 points or 9.45% from its previous closing of Rs. 247.15 on the BSE.

The scrip opened at Rs. 253.10 and has touched a high and low of Rs. 285.00 and Rs. 251.45 respectively. So far 1, 38,752 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 327.80 on 05-Dec-2012 and a 52 week low of Rs. 155.00 on 27-Mar-2012.

Last one week high and low of the scrip stood at Rs. 255.50 and Rs. 239.55 respectively. The current market cap of the company is Rs. 263 crore.

The promoters holding in the company stood at 34.22% while Institutions and Non-Institutions held 14.45% and 51.33% respectively.

Pharmaceutical manufacturing company, Venus Remedies, has reported result for third quarter ended December 31, 2012.

The company’s net profit for the quarter jumped by 55.37% at Rs 16.05 crore as compared to Rs 10.33 crore for the same quarter in the previous financial year. Total income from operation of the company rose by 17.54% at Rs 112.63 crore for quarter under review as compared to Rs 95.82 crore for the quarter ended December 31, 2011.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products. 

Venus Remedies Share Price

745.20 -7.70 (-1.02%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×